
Business
Virginia theranostics program takes shape with Sentara-BAMF
The joint venture is intended to combine radiopharmaceutical production, molecular imaging, molecular therapy, and clinical trials in a vertically integrated model.
Company

The joint venture is intended to combine radiopharmaceutical production, molecular imaging, molecular therapy, and clinical trials in a vertically integrated model.